Heterodimer of b-type transforming growth factors 2 and 3

C - Chemistry – Metallurgy – 12 – N

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C12N 15/62 (2006.01) A61K 38/18 (2006.01) A61K 39/395 (2006.01) C07K 1/36 (2006.01) C07K 14/495 (2006.01) C07K 16/22 (2006.01) C12N 15/18 (2006.01) G01N 33/566 (2006.01) G01N 33/577 (2006.01) G01N 33/74 (2006.01) A61K 38/00 (2006.01)

Patent

CA 2096441

2096441 9208480 PCTABS00013 A new heterodimeric form of TGF-.beta. is described. This 25 KD molecule is active in an in vitro assay of inhibition of epithelial cell growth. The protein may be isolated from bone. When reduced, the protein elutes in two peaks by RP-HPLC. In immunoblots, the reduced protein from the earlier eluting peak reacts predominately with antibodies directed against TGF-.beta.3, while reduced protein from the later eluting peak reacts predominately with antibodies directed against TGF-.beta.2. The N-terminal amino acid sequence and immunoreactivity of the native protein are consistent with a heterodimer of TGF-.beta.2 and TGF-.beta.3.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Heterodimer of b-type transforming growth factors 2 and 3 does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Heterodimer of b-type transforming growth factors 2 and 3, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Heterodimer of b-type transforming growth factors 2 and 3 will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1455780

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.